Specifically, DP9 exhibits robust anti-pancreatic cancer properties, effectively suppressing cell proliferation, inducing apoptosis, arresting the cell cycle at the S phase, and inhibiting angiogenesis and tumor cell migration and invasion. The gene discussed is DPP9; the disease is pancreatic neoplasm.